FDA Drug Application (062349) for NYSTATIN by G AND W LABS INC

Back to FDA Applications sponsored by G AND W LABS INC

Application Number062349
Product Number001
FormSUSPENSION;ORAL
Dosage100,000 UNITS/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameNYSTATIN
Active IngredientNYSTATIN



Back to FDA Applications sponsored by G AND W LABS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.